OTCM
CURLF
Market cap2.60bUSD
Oct 08, Last price
9.44USD
1D
-4.16%
1Q
-0.21%
IPO
159.34%
Name
Curaleaf Holdings Inc
Chart & performance
P/E
—
P/S
1.93
EPS
—
Div yield, %
—
Shrs. gr., 5y
7.16%
Rev. gr., 5y
14.36%
Revenues
1.29b
+0.94%
Net income
-235m
L+3.70%
CFO
140m
-9.32%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.
Key people
Rahul Pinto
President · since 2025
Edward Kremer
Chief Financial Officer · since 2022
Tyneeha Rivers
Chief People Officer · since 2022
Camilo Lyon
Chief Investment Officer · since 2022
James Shorris
Chief Compliance Officer · since 2020
Joseph Lusardi
Executive Vice Chairman of the Board · since 2021
Peter Clateman
Chief Legal Officer · since 2020
Boris Jordan
Chairman of the Board, Chief Executive Officer · since 2024
Michelle Bodner
Non-Executive Director · since 2022
Mitchell Kahn
Non-Executive Director · since 2020
Peter Derby
Independent Director · since 2018
Jaswinder Grover
Independent Director · since 2020
Karl Johansson
Independent Director · since 2018
Shasheen Shah
Independent Director · since 2022
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||